Stryker (NYSE:SYK) said it’s planning to launch a trial during the 1st half of this year to evaluate its newly acquired Mako robotic surgery platform in full-knee replacement procedures.
Orthopedics
Welcome to MassDevice's Orthopedics Hub, your resource for the latest in orthopedic news. Stay informed about the innovations and business news shaping the ortho device industry.
🦴 Narrow your focus with these categories:
Implants | Metal-on-Metal | Spine
Here are the top orthopedic device features from MassDevice and its sister publications (and scroll down to read the latest cardiology device news from MassDevice):
+ The biggest stories from AAOS 2024
+ The 10 largest orthopedic device companies in the world
+ The ZimVie Tether helps kids with scoliosis — if they can get it in time
+ Could 2023 be a boom year for orthopedic devices?
+ The top orthopedic device news out of AAOS 2023
🎙️ Tune in to the Ortho Innovation Talks podcast on the DeviceTalks podcast network.
Latest Orthopedics News
NuVasive must face AngleFix patent infringement lawsuit
Investors balk at J&J’s 2014 guidance despite Q4, 2013 growth
Johnson & Johnson (NYSE:JNJ) shares are down this morning after the healthcare conglomerate said it expects its 2014 earnings to be a penny below expectations and posted strong sales and profit growth for the 4th quarter and 2013.
GPOs: Mazor, RTI Surgical land supply deals
Mazor Robotics (NSDQ:MZOR) announced a deal with an unnamed group purchasing organization for its flagship Renaissance robotic surgery system.
Greatbatch requests CE Mark for spinal cord stim
Greatbatch (NYSE:GB) filed a CE Mark application for its spinal cord stimulation system with German notified body TÜV SÜD America.
Doc convicted of perjury in Orthofix investigation
NuVasive soars on estimates for Q4 and 2014
California medical device maker NuVasive Inc. (NSDQ:NUVA) is flying high today after raising its revenue projections for 2013 amid higher-than-expected 4th quarter sales.
Globus Medical gains a bit on strong Q4 prelims
Globus Medical (NYSE:GMED) blew the doors off of the sluggish growth rate for the spinal implant market during the 4th quarter, topping Wall Street’s expectations and sending share prices up today.
Medicare denies coverage for Vertos’ spinal device, but leaves room for clinical trials
Updated Jan. 10, 2014, at 4:05 p.m. with comments from Vertos.
The Centers for Medicare & Medicaid Services this month issued a final decision memo rejecting reimbursement for lumbar decompression in treatment of spinal stenosis, largely reiterating a proposal issued in October.